Pajares Virginia, Torrego Alfons, Martínnez-Téllez Elisabeth, Trujillo-Reyes Juan Carlos
Respiratory Medicine.
Biomedical Research Institute Sant Pau (IIB-Sant Pau), Barcelona, Spain.
J Clin Transl Res. 2020 Sep 2;6(4):121-126. eCollection 2020 Oct 29.
The diagnosis and staging of lung cancer are an important process that identifies treatment options and guides disease prognosis. Therefore, an accurate mediastinal lymph node (LN) staging is required not only to offer the appropriate treatment but also to avoid unnecessary invasive procedures. At present, endobronchial ultrasound (EBUS)-transbronchial needle aspiration is the preferred modality for sampling mediastinal lymph nodes because of its minimally invasive nature and high diagnostic yield. In this review, we discuss the utility of EBUS in mediastinal LN staging of non-small cell lung cancer (NSCLC).
The use of EBUS-TBNA in the diagnosis of mediastinal and hilar LN pathology has become in an essential endoscopic technique and the first step for staging of lung cancer.
肺癌的诊断和分期是确定治疗方案并指导疾病预后的重要过程。因此，准确的纵隔淋巴结（LN）分期不仅是为了提供合适的治疗，也是为了避免不必要的侵入性操作。目前，由于其微创性和高诊断率，支气管内超声（EBUS）引导下经支气管针吸活检是纵隔淋巴结采样的首选方式。在本综述中，我们讨论了EBUS在非小细胞肺癌（NSCLC）纵隔LN分期中的应用。
EBUS-TBNA在纵隔和肺门LN病变诊断中的应用已成为一项重要的内镜技术，也是肺癌分期的第一步。
